Bank of New York Mellon Corp - SPRING BK PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of SPRING BK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$60,000
-9.1%
45,1390.0%0.00%
Q2 2020$66,000
+57.1%
45,1390.0%0.00%
Q1 2020$42,000
+75.0%
45,139
+199.0%
0.00%
Q4 2019$24,000
-53.8%
15,0960.0%0.00%
Q3 2019$52,000
-7.1%
15,0960.0%0.00%
Q2 2019$56,000
-88.2%
15,096
-66.6%
0.00%
Q1 2019$474,000
+4.4%
45,157
+3.1%
0.00%
Q4 2018$454,000
-8.8%
43,789
+5.9%
0.00%
Q3 2018$498,000
+11.7%
41,359
+9.9%
0.00%
Q2 2018$446,00037,6320.00%
Other shareholders
SPRING BK PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
BVF INC/IL 951,701$9,983,0001.12%
Morse Asset Management, Inc 149,175$1,565,0000.47%
SECTORAL ASSET MANAGEMENT INC 276,656$2,902,0000.35%
PARSONS CAPITAL MANAGEMENT INC/RI 276,963$2,905,0000.32%
CAXTON CORP 23,717$249,0000.23%
TIEDEMANN ADVISORS, LLC 412,049$4,323,0000.20%
Private Capital Advisors, Inc. 52,335$549,0000.17%
Pegasus Asset Management, Inc. 18,750$197,0000.16%
Hikari Power Ltd 53,536$562,0000.06%
SPHERA FUNDS MANAGEMENT LTD. 51,015$535,0000.05%
View complete list of SPRING BK PHARMACEUTICALS IN shareholders